WILMINGTON, Del. (Dec. 16, 2025)—Kentmere Healthcare Consulting Corporation has named Andrew Baskin, MD, formerly of Aetna/CVS, as its new Chief Medical Officer. Since 2000, the company has delivered significant cost savings through its proprietary and highly customized Kentmere Outpatient Laboratory Benefit Management Program™ to local, regional and national health plans.
“Dr. Baskin’s extensive health plan and medical policy experience, combined with his clinical expertise as a Board-Certified internal medicine physician, make him an ideal fit for our CMO role,” said Jeffrey M. Petrizzi, founder and CEO, Kentmere Healthcare Consulting Corporation. “We are confident his leadership will deliver meaningful value to our clients—and we are fortunate to welcome him to our team.”
Dr. Baskin brings more than 40 years of experience in the healthcare industry, including 22 years with Aetna/CVS, where he served in roles such as National Medical Director of Clinical Policy and Quality and Interim Chief Medical Officer. Earlier in his career, he spent 16 years in private practice as an internal medicine physician specializing in geriatrics.
“Laboratory testing continues to be an increasingly critical component of quality medical care,” noted Andrew Baskin, MD. “As new diagnostics, screening tests, genetic-based tests and companion tests enter the market at a rapid pace, I look forward to working with the Kentmere team in helping health plans ensure that patients have access to the most appropriate, evidence-based and cost-effective care available.”
Dr. Baskin is Board-Certified in Internal Medicine. He earned his Doctor of Medicine from Temple University School of Medicine and his Bachelor of Science degree from Temple University in Philadelphia, PA. He completed his internship and residency in Internal Medicine at Lankenau Hospital in Wynnewood, PA.
Dr. Baskin succeeds Russel Kaufman, MD, who served Kentmere with distinction as Chief Medical Officer for the last 12 years. Dr. Kaufman will transition to a scaled-back role as Chief Medical Officer Emeritus and Clinical Advisor effective February 1, 2026.
“Since joining Kentmere in 2014, Dr. Kaufman has been a driving force behind our success, shaping both the growth of our organization and the meaningful impact of our Outpatient Laboratory Benefit Management Program for clients,” noted Jeffrey M. Petrizzi, founder and CEO. “His leadership and clinical expertise have left an enduring mark—and we are honored that he will continue with Kentmere in his new role.”
“I look forward to working with the Kentmere team and will assist Dr. Baskin to make his transition as smooth as possible,” said Russel Kaufman, MD. “I have enjoyed my time working with a great team at Kentmere and the opportunity to experience the tremendous change that has taken place in the diagnostic industry, especially in molecular diagnostics.”